Yaomin Wang

819 total citations
50 papers, 530 citations indexed

About

Yaomin Wang is a scholar working on Nephrology, Molecular Biology and Rheumatology. According to data from OpenAlex, Yaomin Wang has authored 50 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 12 papers in Molecular Biology and 10 papers in Rheumatology. Recurrent topics in Yaomin Wang's work include Renal Diseases and Glomerulopathies (10 papers), Systemic Lupus Erythematosus Research (6 papers) and Pain Mechanisms and Treatments (6 papers). Yaomin Wang is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Systemic Lupus Erythematosus Research (6 papers) and Pain Mechanisms and Treatments (6 papers). Yaomin Wang collaborates with scholars based in China, United States and South Korea. Yaomin Wang's co-authors include Yuqiong Chen, Zhi Yu, Shuai Hu, Chang He, Yu‐Chuan Li, Yi Chen, Dejiang Ni, Youying Tu, Gary O. Rankin and Yon Rojanasakul and has published in prestigious journals such as Oncogene, Pain and Science Translational Medicine.

In The Last Decade

Yaomin Wang

46 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaomin Wang China 14 170 160 92 65 61 50 530
Tingting An China 10 128 0.8× 123 0.8× 90 1.0× 38 0.6× 52 0.9× 18 405
Pengqi Wang China 15 276 1.6× 93 0.6× 45 0.5× 43 0.7× 27 0.4× 26 909
Maomao Sun China 14 373 2.2× 72 0.5× 32 0.3× 91 1.4× 91 1.5× 18 864
Dongjie Wang China 10 247 1.5× 54 0.3× 25 0.3× 69 1.1× 73 1.2× 27 452
Meili Xu China 13 219 1.3× 39 0.2× 26 0.3× 108 1.7× 58 1.0× 37 507
Tatsuya Kuroki Japan 9 238 1.4× 108 0.7× 59 0.6× 28 0.4× 20 0.3× 12 594
Hoda E. Mohamed Egypt 14 131 0.8× 58 0.4× 56 0.6× 16 0.2× 21 0.3× 49 578
Qiaoling He China 14 212 1.2× 71 0.4× 22 0.2× 23 0.4× 15 0.2× 19 544
Mohamed A. Shaheen Egypt 15 265 1.6× 63 0.4× 31 0.3× 38 0.6× 16 0.3× 41 623

Countries citing papers authored by Yaomin Wang

Since Specialization
Citations

This map shows the geographic impact of Yaomin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaomin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaomin Wang more than expected).

Fields of papers citing papers by Yaomin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaomin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaomin Wang. The network helps show where Yaomin Wang may publish in the future.

Co-authorship network of co-authors of Yaomin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaomin Wang. A scholar is included among the top collaborators of Yaomin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaomin Wang. Yaomin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Yi‐Ting, Hong Pan, Junni Wang, et al.. (2025). Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study. Lupus Science & Medicine. 12(1). e001296–e001296. 2 indexed citations
4.
Yang, Ye, et al.. (2024). Genomic characterization of WRKY transcription factors related to secoiridoid biosynthesis in Gentiana macrophylla. BMC Plant Biology. 24(1). 66–66. 8 indexed citations
5.
Wang, Yaomin, Shin Hyung Kim, Marguerita E. Klein, et al.. (2024). A mouse model of chronic primary pain that integrates clinically relevant genetic vulnerability, stress, and minor injury. Science Translational Medicine. 16(742). eadj0395–eadj0395. 3 indexed citations
6.
Lin, Yuxin, Quan Han, Junni Wang, et al.. (2024). Obinutuzumab May Be an Effective and Safe Option for Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis Patients after Multitarget Therapy Including Rituximab. American Journal of Nephrology. 56(1). 1–10. 2 indexed citations
7.
Liu, Guangjun, Yaomin Wang, Pingping Ren, et al.. (2024). Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis. BMC Nephrology. 25(1). 473–473. 2 indexed citations
8.
Pan, Yixuan, Lan Lan, Yaomin Wang, et al.. (2024). Hydroxychloroquine Induces Remission for IgA Nephropathy With Mild to Moderate Proteinuria: A Single-Centered Retrospective Analysis. Cureus. 16(2). e53395–e53395. 1 indexed citations
9.
Xie, Wenqin, Suya Wang, Yilin Zhu, et al.. (2023). Associated factors of osteoporosis and vascular calcification in patients awaiting kidney transplantation. International Urology and Nephrology. 55(12). 3217–3224. 1 indexed citations
11.
Wang, Luming, Jia-Cong Liu, Yaomin Wang, Linhai Zhu, & Jian Hu. (2023). Minimally invasive surgery for pleuroperitoneal communication complicating peritoneal dialysis. International Urology and Nephrology. 55(12). 3189–3195. 1 indexed citations
12.
Song, Yujuan, Yaomin Wang, Yichen Liao, et al.. (2021). Transcriptomic and proteomic analysis of putative digestive proteases in the salivary gland and gut of Empoasca (Matsumurasca) onukii Matsuda. BMC Genomics. 22(1). 271–271. 7 indexed citations
13.
Wang, Yaomin, et al.. (2021). Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome. Clinical & Translational Oncology. 23(11). 2237–2252. 8 indexed citations
14.
Huang, Xiaohan, Liangliang Chen, Lan Lan, et al.. (2021). Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome. Frontiers in Immunology. 12. 641655–641655. 4 indexed citations
15.
Chen, Liangliang, Xiaohan Huang, Yanhong Ma, et al.. (2021). The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center. Clinical and Experimental Medicine. 21(3). 389–397. 8 indexed citations
16.
Hu, Shuai, Chang He, Yu‐Chuan Li, et al.. (2021). Changes of fungal community and non-volatile metabolites during pile-fermentation of dark green tea. Food Research International. 147. 110472–110472. 73 indexed citations
18.
Zhang, Xiaohui, Xishao Xie, Junni Wang, et al.. (2019). High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study. Nutrition & Metabolism. 16(1). 52–52. 19 indexed citations
19.
Zhang, Qilong, Junni Wang, Yaomin Wang, et al.. (2018). Effects of serum uric acid level on all-cause death and cardiovascular death in patients of maintaining peritoneal dialysis. 34(11). 809–815. 3 indexed citations
20.
Wang, Yaomin, et al.. (2017). 3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cells. International Journal of Oncology. 50(4). 1392–1402. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026